| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Director
3 companies
Elkins David V is an EVP, Chief Financial Officer at CELG-RI with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $10.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | BMY Bristol Myers Squibb Co | EVP, Chief Financial Officer | Sell | 56,000 | $47.33 | $2,650,480.00 | -25.1% | +3.7% | - | |
| Sep 13, 2022 | BMY Bristol Myers Squibb Co | EVP, Chief Financial Officer | Sale+OE | 133,951 | $71.30 | $9,551,166.79 | -37.8% | +11.9% | -15.4% | |
| Aug 12, 2021 | BMY Bristol Myers Squibb Co | EVP, Chief Financial Officer | Sale+OE | 99,691 | $66.95 | $6,674,497.00 | -40.0% | -10.6% | +16.4% |